Headline
The latest stories from AHA Today.
The Centers for Medicare & Medicaid Services does not intend for Paycheck Protection Program funds to impact Medicare payments to rural hospitals, CMS Administrator Seema Verma said in a tweet.
Sens. Mark Warner, D-Va., and Tim Scott, R-S.C., introduced the Getting Early Treatment and Comprehensive Assessments Reduces Emergencies (GET CARE) Act, which would encourage patients to continue seeking preventive care during the COVID-19 pandemic, including disseminating scientific and evidence-…
Michigan-based Trinity Health’s Transforming Communities Initiative is a “think big” approach to health care, targeting such underlying problems as youth tobacco use and childhood obesity.
The Centers for Disease Control and Prevention this week launched Hear Her, a new campaign to raise awareness of pregnancy-related complications, risks and death.
The Substance Abuse and Mental Health Services Administration’s Office of Behavioral Health Equity recently published a report on the opioid crisis’ impact on the Hispanic and Latino populations.
The Centers for Medicare & Medicaid Services released wage data to help hospitals assess whether to seek reclassification of their Medicare area wage index for fiscal year 2022.
Virginia launched the first COVID-19 contact tracing app based on the exposure notifications system application programming interface developed by Apple and Google.
Hospitals have treated at least 15 patients in Arizona and New Mexico for methanol poisoning associated with alcohol-based hand sanitizers, according to a report released by the Centers for Disease Control and Prevention. Six of the patients developed seizures, four died and three were discharged…
The National Institutes of Health announced the Medical Imaging and Data Resource Center, a public-private initiative that will create medical imaging tools to detect and personalize therapies for COVID-19 patients.
The National Institute of Allergy and Infectious Diseases has launched a clinical trial to evaluate a potential COVID-19 treatment regimen for hospitalized patients that combines remdesivir with interferon beta-1a, a medication approved to treat multiple sclerosis that laboratory studies suggest…